DJ US Medical Devices Ishares (IHI) 124.97 $IHI Warning:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DJ US Medical Devices Ishares (IHI) 124.97 $IHI

Warning: Top Healthcare Performers Now Overvalued
Wall Street Daily - at Seeking Alpha - Mon Jun 15, 10:48AM CDT
By Chris Worthington Over the past five years, one sector has outperformed all others in the S&P 500: healthcare. Biotech stocks have led the way, with the Nasdaq Biotechnology Index climbing a whopping 520% since early 2009. The...
BBP: 35.46 (-0.85), THQ: 19.80 (-0.19), HQL: 29.21 (-0.10), RXL: 77.29 (-0.09), XBI: 251.76 (-7.18), IBB: 376.06 (-6.78), LABU: 46.20 (-3.84), IHE: 180.72 (-1.47), IHF: 139.01 (+0.05), XHE: 96.98 (+0.28), BBC: 35.81 (-0.86), PPH: 74.19 (+0.25), PTH: 63.95 (-1.31), BBH: 137.08 (-1.97), FHLC: 36.87 (-0.08), IHI: 124.97 (-0.14), CURE: 41.64 (+0.04), VHT: 142.83 (-0.25), FXH: 68.86 (-0.15), RYH: 162.41 (-0.19), PBE: 58.45 (-1.47), IYH: 162.03 (-0.07), FBT: 124.16 (-2.44), XHS: 129.65 (+0.52), XPH: 130.16 (-1.82), XLV: 76.18 (+0.05), SBIO: 37.55 (-0.95), PSCH: 72.69 (-0.48), PJP: 81.02 (-0.62), MRK: 58.57 (+1.05), RXD: 45.38 (-1.49), HQH: 35.82 (+0.23), LABD: 30.00 (+2.05)

BUYINS.NET: EET, IHI, SNCR, FXA, UDN, AAXJ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jun 10, 7:18AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra MSCI Emerging Markets (NYSE:EET), iShares Dow Jones US Medical Devices Index Fund (NYSE:IHI), SYNCHRONOSS TECHNOLOGIES, INC. (NASDAQ:SNCR), CurrencyShares Australian Dollar Trust (NYSE:FXA), Powershares Db Us $ Index (NYSE:UDN), iShares MSCI All Country Asia ex Japan Index Fund (NASDAQ:AAXJ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AAXJ: 59.53 (+0.39), SNCR: 46.82 (+2.55), FXA: 73.29 (-0.07), EET: 59.47 (+1.31), UDN: 21.83 (-0.03), IHI: 124.97 (-0.14)

Is The Healthcare Sector Rolling Over?
Matt Erickson - Seeking Alpha - Wed Apr 29, 7:04AM CDT
In a number of our previously published articles (including The Beginning Of The End , as well as in Choosing The Right Healthcare ETF ) we have made mention of the relatively dramatic outperformance we have seen in the healthcare sector year to...
RYH: 162.41 (-0.19), IHF: 139.01 (+0.05), PJP: 81.02 (-0.62), IBB: 376.06 (-6.78), IHI: 124.97 (-0.14), FXH: 68.86 (-0.15), XLV: 76.18 (+0.05)

BUYINS.NET: FLM, IPN, JO, KOL, PBP, IHI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Apr 16, 7:17AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Ise Global Engineering And Construction Index Fu (NYSE:FLM), SPDR S&P International Industrial Sector ETF (NYSE:IPN), IPATH DJ-UBS COFFEE SUBINDEX (NYSE:JO), Market Vectors Coal ETF (NYSE:KOL), PowerShares S&P 500 BuyWrite Portfolio (NYSEBP), iShares Dow Jones US Medical Devices Index Fund (NYSE:IHI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
JO: 20.44 (+0.43), FLM: 46.86 (+0.70), KOL: 9.78 (+0.06), IHI: 124.97 (-0.14), PBP: 21.52 (+0.06), IPN: 29.74 (+0.03)

Government to raise Medicare Advantage rates, not cut them
Seeking Alpha - at Seeking Alpha - Tue Apr 07, 6:14AM CDT

RYH: 162.41 (-0.19), IYH: 162.03 (-0.07), RXL: 77.29 (-0.09), XHS: 129.65 (+0.52), UNH: 121.38 (-0.14), MO: 54.50 (-0.75), AET: 111.46 (-0.85), HNT: 65.95 (-0.09), HUM: 182.67 (-1.85), XLV: 76.18 (+0.05), IHF: 139.01 (+0.05), XHE: 96.98 (+0.28), PSCH: 72.69 (-0.48), PTH: 63.95 (-1.31), RXD: 45.38 (-1.49), IHI: 124.97 (-0.14), VHT: 142.83 (-0.25), FXH: 68.86 (-0.15)

12 Best Biotech and Health Care ETFs to Add to Your Portfolio
at The Street - Thu Mar 12, 9:49AM CDT
Biotech and health care are two of the hottest sectors in which to invest. TheStreet compiled a list of the best-rated ETFs tracking the two sectors.
IHE: 180.72 (-1.47), IHF: 139.01 (+0.05), XHE: 96.98 (+0.28), IYH: 162.03 (-0.07), XHS: 129.65 (+0.52), GRX: 11.30 (+0.03), FHLC: 36.87 (-0.08), IHI: 124.97 (-0.14), IXJ: 112.57 (+0.49), VHT: 142.83 (-0.25), FXH: 68.86 (-0.15), XLV: 76.18 (+0.05)

Notable ETF Outflow Detected - IHI, MDT, ABT, TMO
ETFChannel.com - Wed Feb 11, 9:52AM CST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares US Medical Devices ETF where we have detected an approximate $80.8 million dollar outflow -- that's a 10.5%...
IHI: 124.97 (-0.14)

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 35.46 (-0.85), RXL: 77.29 (-0.09), XBI: 251.76 (-7.18), IHE: 180.72 (-1.47), IHF: 139.01 (+0.05), PPH: 74.19 (+0.25), XHE: 96.98 (+0.28), BBC: 35.81 (-0.86), PTH: 63.95 (-1.31), BBH: 137.08 (-1.97), FHLC: 36.87 (-0.08), IHI: 124.97 (-0.14), CURE: 41.64 (+0.04), FXH: 68.86 (-0.15), VHT: 142.83 (-0.25), RYH: 162.41 (-0.19), PBE: 58.45 (-1.47), IYH: 162.03 (-0.07), FBT: 124.16 (-2.44), XHS: 129.65 (+0.52), XPH: 130.16 (-1.82), XLV: 76.18 (+0.05), SBIO: 37.55 (-0.95), PSCH: 72.69 (-0.48), PJP: 81.02 (-0.62), RXD: 45.38 (-1.49)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 35.46 (-0.85), RXL: 77.29 (-0.09), XBI: 251.76 (-7.18), IBB: 376.05 (-6.79), IHE: 180.72 (-1.47), IHF: 139.01 (+0.05), BBC: 35.81 (-0.86), PPH: 74.19 (+0.25), XHE: 96.98 (+0.28), PTH: 63.95 (-1.31), BBH: 137.08 (-1.97), FHLC: 36.87 (-0.08), IHI: 124.97 (-0.14), CURE: 41.64 (+0.04), FXH: 68.86 (-0.15), VHT: 142.83 (-0.25), RYH: 162.41 (-0.19), PBE: 58.45 (-1.47), IYH: 162.03 (-0.07), FBT: 124.16 (-2.44), XHS: 129.65 (+0.52), XPH: 130.16 (-1.82), XLV: 76.18 (+0.05), SBIO: 37.55 (-0.95), PSCH: 72.69 (-0.48), PJP: 81.02 (-0.62), RXD: 45.38 (-1.49)

iShares U.S. Medical Devices ETF Experiences Big Outflow
ETFChannel.com - Tue Nov 18, 10:01AM CST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares US Medical Devices ETF where we have detected an approximate $32.7 million dollar outflow -- that's a 4.2%...
IHI: 124.97 (-0.14)

3 Sector ETFs Cheering Mid-Term Republican Win - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Nov 10, 12:00PM CST
Though these sector ETFs have seen volatile trading over teh past week, they will benefit most once Republican gain full control over Congress in January.
ITA: 118.76 (+2.15), IHI: 124.97 (-0.14), XLE: 71.08 (+0.61)

ETFs Set To Move On GOP Victory
Benzinga - Seeking Alpha - Fri Nov 07, 10:16AM CST
By Matthew McCall The Republicans pulled off a historic night in the mid-term elections as they took over the Senate and won several gubernatorial swing states. The Senate is the most important outcome of mid-term elections and it has several...
AMLP: 15.55 (+0.14), IHI: 124.97 (-0.14)

ETFs Slipping to Rank #5 this Earnings Season - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Oct 27, 1:00PM CDT
Given weak corporate earnings and huge levels of stock market volatility, several ETFs have slipped to Zacks ETF Rank of 5.
XTL: 56.25 (+0.23), BJK: 36.78 (+0.29), IHI: 124.97 (-0.14)

Stock Picking Grades For Health Care Sector Fund Managers
David Trainer - Seeking Alpha - Wed Oct 22, 8:30AM CDT
This report shows how well Health Care ETFs and mutual fund managers pick stocks. We juxtapose our Portfolio Management rating on funds, which grades managers based on the quality of the stocks they choose, with the number of good stocks available...
VRTX: 126.94 (-1.36), MDT: 77.35 (-0.12), XBI: 251.76 (-7.18), IHI: 124.97 (-0.14)

Medical Device ETF in Focus on Recent Merger Activity - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Oct 09, 7:02AM CDT
Recent deals on the merger and acquisition front puts the Medical Device ETF (IHI) in focus.
BDX: 151.14 (+1.26), MDT: 77.35 (-0.12), CFN: 59.91 (-0.06), COV: 106.71 (-1.36), IHI: 124.97 (-0.14)

Bet On This Top Ranked Medical Device ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Aug 11, 5:07AM CDT
This top ranked ETF may be a good defensive bet in the current volatile market environment.
ABT: 51.00 (+0.06), XPH: 130.16 (-1.82), IHI: 124.97 (-0.14), XLV: 76.18 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading